Works matching IS 03682811 AND DT 2019 AND VI 49 AND IP 12


Results: 17
    1

    A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study)

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1172, doi. 10.1093/jjco/hyz169
    By:
    • Kadota, Tomohiro;
    • Saito, Ryuta;
    • Kumabe, Toshihiro;
    • Mizusawa, Junki;
    • Katayama, Hiroshi;
    • Sumi, Minako;
    • Igaki, Hiroshi;
    • Kinoshita, Manabu;
    • Komori, Takashi;
    • Ichimura, Koichi;
    • Narita, Yoshitaka;
    • Nishikawa, Ryo
    Publication type:
    Article
    2

    Thanking All Peer Reviewers.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1068, doi. 10.1093/jjco/hyz191
    Publication type:
    Article
    3
    4

    "JJCO Best Reviewer Award".

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1072, doi. 10.1093/jjco/hyz189
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein–Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1100, doi. 10.1093/jjco/hyz109
    By:
    • Kitpanit, Sarin;
    • Jittapiromsak, Nutchawan;
    • Sriyook, Aniwat;
    • Prayongrat, Anussara;
    • Kannarunimit, Danita;
    • Chakkabat, Chakkapong;
    • Lertbutsayanukul, Chawalit
    Publication type:
    Article
    16
    17